These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16529528)

  • 1. Sertindole : a review of its use in schizophrenia.
    Murdoch D; Keating GM
    CNS Drugs; 2006; 20(3):233-55. PubMed ID: 16529528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
    Daniel DG; Wozniak P; Mack RJ; McCarthy BG
    Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of the efficacy, tolerability and safety of sertindole in clinical trials.
    Perquin L; Steinert T
    CNS Drugs; 2004; 18 Suppl 2():19-30; discussion 41-3. PubMed ID: 15461313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging treatments in the management of schizophrenia - focus on sertindole.
    Muscatello MR; Bruno A; Pandolfo G; Micò U; Settineri S; Zoccali R
    Drug Des Devel Ther; 2010 Sep; 4():187-201. PubMed ID: 20856845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug safety and efficacy evaluation of sertindole for schizophrenia.
    Karamatskos E; Lambert M; Mulert C; Naber D
    Expert Opin Drug Saf; 2012 Nov; 11(6):1047-62. PubMed ID: 22992213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of sertindole in schizophrenia: a clinical review.
    Zoccali RA; Bruno A; Muscatello MR
    J Clin Psychopharmacol; 2015 Jun; 35(3):286-95. PubMed ID: 25830594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL; Kane JM; Tamminga CA; Daniel DG; Mack RJ; Wozniak PJ; Sebree TB; Wallin BA; Kashkin KB
    Am J Psychiatry; 1997 Jun; 154(6):782-91. PubMed ID: 9167505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, controlled study of sertindole versus risperidone in the treatment of moderate-to-severe schizophrenia.
    Azorin JM; Strub N; Loft H
    Int Clin Psychopharmacol; 2006 Jan; 21(1):49-56. PubMed ID: 16317317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertindole in schizophrenia: efficacy and safety issues.
    Muscatello MR; Bruno A; Micali Bellinghieri P; Pandolfo G; Zoccali RA
    Expert Opin Pharmacother; 2014 Sep; 15(13):1943-53. PubMed ID: 25084209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case histories illustrating the utility of sertindole in clinical practice.
    Schuck P; van den Ameele H; Jaanson P; Ryckmans V; Hawley C
    CNS Drugs; 2004; 18 Suppl 2():31-40; discussion 41-3. PubMed ID: 15461314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertindole: new drug. Another "atypical" neuroleptic; QT prolongation.
    Prescrire Int; 2007 Apr; 16(88):59-62. PubMed ID: 17458045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sertindole: efficacy and safety in schizophrenia.
    Lindström E; Levander S
    Expert Opin Pharmacother; 2006 Sep; 7(13):1825-34. PubMed ID: 16925508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The European post-marketing observational sertindole study: an investigation of the safety of antipsychotic drug treatment.
    Kasper S; Möller HJ; Hale A
    Eur Arch Psychiatry Clin Neurosci; 2010 Feb; 260(1):59-68. PubMed ID: 19455275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sertindole for the treatment of schizophrenia.
    Azorin JM; Kaladjian A; Fakra E; Adida M
    Expert Opin Pharmacother; 2010 Dec; 11(18):3053-64. PubMed ID: 21080854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The atypical antipsychotic sertindole: a case series.
    Lee AM; Knoll JL; Suppes T
    J Clin Psychiatry; 1997 Sep; 58(9):410-6; quiz 417-8. PubMed ID: 9378698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled, dose-ranging trial of sertindole in patients with schizophrenia.
    van Kammen DP; McEvoy JP; Targum SD; Kardatzke D; Sebree TB
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):168-75. PubMed ID: 8935813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral effects of sertindole, risperidone, clozapine and haloperidol in Cebus monkeys.
    Casey DE
    Psychopharmacology (Berl); 1996 Mar; 124(1-2):134-40. PubMed ID: 8935808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The European Post-marketing Observational Serdolect (EPOS) Project: increasing our understanding of schizophrenia therapy.
    Wehnert A
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S27-30. PubMed ID: 9690967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia in Sweden.
    Lindström E; Eberhard J; Fors BM; Hansen K; Sapin C
    Nord J Psychiatry; 2011 Dec; 65(6):403-13. PubMed ID: 21770821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Schizophrenic psychoses: distinct therapeutic advantages of atypical neuroleptics. Serdolect is effective and free of side effects].
    Psychiatr Prax; 1998 Sep; 25(5 Suppl):1-4. PubMed ID: 9802117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.